Advanced search
Publication Cover
Journal of Drug Targeting Volume 19, 2011 - Issue 8
Submit an article Journal homepage
215
Views
18
CrossRef citations to date
0
Altmetric
Research Article

In vitro optimization of liposomal nanocarriers prepared from breast tumor cell specific phage fusion protein

Tao WangCenter for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, USA
,
Nikita KulkarniCenter for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, USA
,
Deepa BediDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, AL, USA
,
Gerard GM D’Souza
,
Brigitte Papahadjopoulos-SternbergNanoanalytical Laboratory, San Francisco, CA, USA
,
Valery A. PetrenkoDepartment of Pathobiology, College of Veterinary Medicine, Auburn University, AL, USA
&
Vladimir P. TorchilinCenter for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, USACorrespondence[email protected]
 show all
Pages 597-605 | Received 10 Sep 2010, Accepted 22 Dec 2010, Published online: 29 Jan 2011

References

  • Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. (2008). New frontiers in nanotechnology for cancer treatment. Urol Oncol, 26, 74–85.
  • D’Souza GG, Wang T, Rockwell K, Torchilin VP. (2008). Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro. Pharm Res, 25, 2567–2572.
  • Emerich DF, Thanos CG. (2008). Multifunctional peptide-based nanosystems for improving delivery and molecular imaging. Curr Opin Mol Ther, 10, 132–139.
  • Gallusser A, Kuhn A. (1990). Initial steps in protein membrane insertion. Bacteriophage M13 procoat protein binds to the membrane surface by electrostatic interaction. EMBO J, 9, 2723–2729.
  • Jayanna PK, Bedi D, Gillespie JW, DeInnocentes P, Wang T, Torchilin VP, Bird RC, Petrenko VA. (2010). Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiency. Nanomedicine, 6, 538–546.
  • Jayanna PK, Torchilin VP, Petrenko VA. (2009). Liposomes targeted by fusion phage proteins. Nanomedicine, 5, 83–89.
  • Krumpe LR, Mori T. (2006). The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs. Int J Pept Res Ther, 12, 79–91.
  • Kuhn A, Rohrer J, Gallusser A. (1990). Bacteriophages M13 and Pf3 tell us how proteins insert into the membrane. J Struct Biol, 104, 38–43.
  • Lewis GA, Mathieu D,Phan-Tan-Lun R. (1999). Pharmaceutical Experimental Design. New York.
  • Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol, 2, 751–760.
  • Petrenko V. (2008). Evolution of phage display: from bioactive peptides to bioselective nanomaterials. Expert Opin Drug Deliv, 5, 825–836.
  • Petrenko VA, Smith GP, Gong X, Quinn T. (1996). A library of organic landscapes on filamentous phage. Protein Eng, 9, 797–801.
  • Romanov VI, Durand DB, Petrenko VA. (2001). Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate, 47, 239–251.
  • Samoylova TI, Petrenko VA, Morrison NE, Globa LP, Baker HJ, Cox NR. (2003). Phage probes for malignant glial cells. Mol Cancer Ther, 2, 1129–1137.
  • Soekarjo M, Eisenhawer M, Kuhn A, Vogel H. (1996). Thermodynamics of the membrane insertion process of the M13 procoat protein, a lipid bilayer traversing protein containing a leader sequence. Biochemistry, 35, 1232–1241.
  • Sofou S. (2007). Surface-active liposomes for targeted cancer therapy. Nanomedicine (Lond), 2, 711–724.
  • Sofou S, Sgouros G. (2008). Antibody-targeted liposomes in cancer therapy and imaging. Expert Opin Drug Deliv, 5, 189–204.
  • Takayama K, Fujikawa M, Obata Y, Morishita M. (2003). Neural network based optimization of drug formulations. Adv Drug Deliv Rev, 55, 1217–1231.
  • Wang T, D’Souza GG, Bedi D, Fagbohun OA, Potturi LP, Papahadjopoulos-Sternberg B, Petrenko VA, Torchilin VP. (2010). Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein. Nanomedicine (Lond), 5, 563–574.
  • Wang T, Petrenko VA, Torchilin VP. (2010). Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity. Mol Pharm, 7, 1007–1014.
  • Wang T, Yang S, Petrenko VA, Torchilin VP. (2010). Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein. Mol Pharm, 7, 1149–1158.
  • Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, Fang X. (2009). Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm, 376, 176–185.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.